vriddhi 2024: The Indian pharma industry comes together to deliberate on glorious future
Mehul Shah, Honorary General Secretary, Indian Drug Manufacturers' Association (IDMA) and Managing Director of Encube Ethicals…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
Sustainable pharmaceuticals: Addressing environmental concerns
Dr Amit Pandit, School of Pharmacy & Technology Management, NMIMS, Indore & Shirpur Campuses, explores the imperative for…
Exploring new avenues to treat Alzheimer’s
Dr Devendra Kumar, Assistant Professor, NMIMS SPTM Shirpur shares details of his study In funded by the ICMR. He informs that his…
Fostering inclusion: Empowering women in STEM
Sridevi Khambhampaty, VP - Biopharmaceutical Development, Syngene International, gives an overview of the evolving landscape of…
Innovations paving the way for drug discovery of rare diseases
Sanjay Vyas, Executive VP and MD, Parexel examines the challenges associated with rare diseases in India, and emphasises on the…
Sustainable practices in parenteral medicine manufacturing: Need of the hour
Srivardhan Khemka, Director, Sanjivani Parenteral explains that pharma industry in India is undergoing a transformative shift…
How flexibility fuels innovation in India’s pharma and healthcare
Yeshasvini Ramaswamy, Serial Entrepreneur & CEO, Great Place To Work India explores how embracing flexibility not only…
From genes to greens: Recombinant revolution in nutraceuticals
Recombinant technology holds transformative potential in nutraceuticals. However, while presenting opportunities for enhanced…
Complying with DPDP 2023
Diwakar Dayal, Managing Director & Country Manager at SentinelOne explains the provisions of the Digital Personal Data…
Pharma supply chain: From fragile to agile
Sharmishtha Niyogi, Supply Chain Director at Merck, sheds light on the pivotal role of advanced technologies, strategic…
Navigating the seas of change: Leadership in the age of disruption
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) opines that leadership in this era of…
Embracing single-use technologies to advance biopharma manufacturing
Manoj K Ramakrishna, Biopharma Commercial Leader-South Asia, Cytiva Lifesciences talks about Single-Use Technologies (SUTs) and…
Building resilience and rethinking strategies for growth: Pharma in focus
Mukesh Khare, Partner & Head-India Operations, Kaizen Institute highlights that aspiring to become a hub for cost-effective…
As we look ahead to 2024, pharma sector is poised for sustained growth and innovation
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) shares that in 2024, we anticipate a…
Cracking the code – Generic vs. Brand Medicines
Dr Suresh Saravdekar, Former Assistant Director, Ministry of Medical Education & Research and Honorary Consultant, Institute…
Generative AI with Google Lens to detect counterfeits in pharma
Amaninder Singh Dhillon, Consultant explains how combining generative AI and image recognition can help create a more efficient…
Is India capable of ensuring equitable access to biopharmaceuticals?
By introducing cost-effective drugs for critical illness by leveraging path-breaking manufacturing technologies, India could…
Delayed payments to pharma MSMEs: A major challenge
Delayed payments put SMEs at a disadvantage compared to large size counterparts, inhibiting their ability to compete effectively…
Harmony, consistency and unison amongst medical practices in India: Is the gap bridging or widening?
Dr Ashok Omray, Advisor, Pharma Industry and Academic Institutions says that we need to bridge the gaps and claims from different…
Three lessons from Pharmanovia’s ESG Report
Neeshe Williams, General Counsel and Head of ESG at Pharmanovia opines that the pharma industry has renewed its focus on…